<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8006933</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4649</journal-id>
<journal-id journal-id-type="nlm-ta">J Dev Behav Pediatr</journal-id>
<journal-id journal-id-type="iso-abbrev">J Dev Behav Pediatr</journal-id>
<journal-title-group>
<journal-title>Journal of developmental and behavioral pediatrics : JDBP</journal-title>
</journal-title-group>
<issn pub-type="ppub">0196-206X</issn>
<issn pub-type="epub">1536-7312</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26372046</article-id>
<article-id pub-id-type="pmc">4586411</article-id>
<article-id pub-id-type="doi">10.1097/DBP.0000000000000210</article-id>
<article-id pub-id-type="manuscript">NIHMS709899</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Behavioral and Psychiatric Phenotypes in 22q11.2 Deletion Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kates</surname>
<given-names>Wendy R.</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A1">Professor, State University of New York Upstate Medical University, Psychiatry and Behavioral Sciences, 750 East Adams Street, Syracuse, NY 13210, UNITED STATES, 315-464-3270, FAX: 315-464-3163</aff>
<email>katesw@upstate.edu</email>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Kerri L</given-names>
</name>
<degrees>MA</degrees>
<aff id="A2">SUNY Upstate Medical University</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Antshel</surname>
<given-names>Kevin M</given-names>
</name>
<degrees>Ph.D.</degrees>
<aff id="A3">Syracuse University</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fremont</surname>
<given-names>Wanda P.</given-names>
</name>
<degrees>M.D.</degrees>
<aff id="A4">SUNY Upstate Medical University</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="conflict" id="FN1">
<p>
<bold>Conflicts of Interest</bold>
</p>
<p>The authors have no conflicts of interest to declare</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>8</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>36</volume>
<issue>8</issue>
<fpage>639</fpage>
<lpage>650</lpage>
<!--elocation-id from pubmed: 10.1097/DBP.0000000000000210-->
<abstract>
<p id="P1">22q11.2DS is a chromosomal microdeletion that affects approximately 40â€“50 genes, and impacts various organs and systems throughout the body. Detection is typically achieved by fluorescence in-situ hybridization following diagnosis of one of the major features of the deletion or via chromosomal microarray or non-invasive prenatal testing. The physical phenotype can include congenital heart defects, palatal and pharyngeal anomalies, hypocalcemia/hypoparathyroidism, skeletal abnormalities, and cranial/brain anomalies, although prevalence rates of all of these features are variable. Cognitive function is impaired to some degree in most individuals, with prevalence rates of greater than 90% for motor/speech delays and learning disabilities. Attention, executive function, working memory, visual spatial abilities, motor skills, and social cognition/social skills are affected. The deletion is also associated with an increased risk for behavioral disorders and psychiatric illness. The early onset of psychiatric symptoms common to 22q11.2DS disrupts the development and quality of life of individuals with the syndrome, and is also a potential risk factor for later development of a psychotic disorder. This review discusses prevalence, phenotypic features, and management of psychiatric disorders commonly diagnosed in children and adolescents with 22q11.2DS, including autism spectrum disorders, attention deficit/hyperactivity disorder, anxiety disorders, mood disorders, and schizophrenia/psychotic disorders. Guidelines for the clinical assessment and management of psychiatric disorders in youth with this syndrome are provided, as are treatment guidelines for the use of psychiatric medications.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>